Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

76.94

-1.12 (-1.43%)

At close: May 22, 2026, 4:00 PM EDT

76.42

-0.52 (-0.67%)

After-hours: May 22, 2026, 7:38 PM EDT

Cytokinetics Revenue by Segment

Period Ending	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
License	76.28M	64.35M	64.35M	64.35M	-	-	-	-
Milestone	15.00M	15.00M	15.00M	15.00M	15.00M	15.00M	1.00M	1.00M
Milestone Growth	-	-	1,400.00%	1,400.00%	1,400.00%	328.57%	-60.00%	-60.00%
Research and Development	9.74M	8.69M	7.86M	6.39M	4.22M	3.47M	2.22M	2.13M
Research and Development Growth	131.01%	150.03%	254.12%	199.20%	53.27%	-13.80%	-58.25%	-71.36%
Net Product	4.79M	-	-	-	-	-	-	-

Source: Business metrics provided by TipRanks and sourced from official company press releases and documents.